Cargando…

Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington’s disease monkeys

BACKGROUND: Huntington’s Disease (HD) is a progressive neurodegenerative disorder caused by an expansion in the polyglutamine (polyQ) region of the Huntingtin (HTT) gene. The clinical features of HD are characterized by cognitive, psychological, and motor deficits. Molecular instability, a core comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocerha, Jannet, Liu, Yuhong, Willoughby, David, Chidamparam, Kumaravel, Benito, Joseph, Nelson, Kate, Xu, Yan, Chi, Tim, Engelhardt, Heidi, Moran, Sean, Yang, Shang-Hsun, Li, Shi-Hua, Li, Xiao-Jiang, Larkin, Katherine, Neumann, Adam, Banta, Heather, Yang, Jin Jing, Chan, Anthony WS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751855/ https://www.ncbi.nlm.nih.gov/pubmed/23957861 http://dx.doi.org/10.1186/1471-2202-14-88

Ejemplares similares

microRNA-128a dysregulation in transgenic Huntington’s disease monkeys
por: Kocerha, Jannet, et al.
Publicado: (2014)

A two years longitudinal study of a transgenic Huntington disease monkey
por: Chan, Anthony WS, et al.
Publicado: (2014)

Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington’s Disease Monkeys
por: Clever, Faye, et al.
Publicado: (2019)

Characterization of dental pulp stem/stromal cells of Huntington monkey tooth germs
por: Snyder, Brooke R, et al.
Publicado: (2011)

Monkey hybrid stem cells develop cellular features of Huntington's disease
por: Laowtammathron, Chuti, et al.
Publicado: (2010)

Developmental Whole Brain White Matter Alterations in Transgenic Huntington’s Disease Monkey
por: Meng, Yuguang, et al.
Publicado: (2017)

CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington’s Disease Monkeys
por: Cho, In K., et al.
Publicado: (2022)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
por: Kocerha, Jannet, et al.
Publicado: (2011)

Reversal of Cellular Phenotypes in Neural Cells Derived from Huntington’s Disease Monkey-Induced Pluripotent Stem Cells
por: Carter, Richard L., et al.
Publicado: (2014)

Progressive Cognitive Deficit, Motor Impairment and Striatal Pathology in a Transgenic Huntington Disease Monkey Model from Infancy to Adulthood
por: Chan, Anthony W. S., et al.
Publicado: (2015)

miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington’s Disease Monkey Neural Cells
por: Kunkanjanawan, Tanut, et al.
Publicado: (2016)

The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
por: Chan, Anthony W. S., et al.
Publicado: (2012)

Advances in non-coding RNA profiling for neurological diseases
por: Cairns, Murray J., et al.
Publicado: (2013)

Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey
por: Chan, Anthony W.S., et al.
Publicado: (2022)

The Potential for microRNA Therapeutics and Clinical Research
por: Hanna, Johora, et al.
Publicado: (2019)

MicroRNA Networks in Cognition and Dementia
por: Blount, Grace S., et al.
Publicado: (2022)

Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease
por: Kocerha, Jannet, et al.
Publicado: (2015)

Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013)

Amelioration of Huntington’s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington’s disease monkeys
por: Cho, In Ki, et al.
Publicado: (2019)

Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System
por: Carrick, William T., et al.
Publicado: (2016)

Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
por: Mees, Isaline, et al.
Publicado: (2022)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Lessons Learned from the Transgenic Huntington's Disease Rats
por: Vlamings, Rinske, et al.
Publicado: (2012)

Striatal microRNA controls cocaine intake through CREB signaling
por: Hollander, Jonathan A., et al.
Publicado: (2010)

Monkey Steering Responses Reveal Rapid Visual-Motor Feedback
por: Egger, Seth W., et al.
Publicado: (2010)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
por: McConoughey, Stephen J, et al.
Publicado: (2010)

Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington’s Disease
por: Tousley, Adelaide, et al.
Publicado: (2019)

Cloning and base editing of GFP transgenic rhesus monkey and off-target analysis
por: Kang, Yu, et al.
Publicado: (2022)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington’s Disease
por: Lallani, Shoeb B., et al.
Publicado: (2019)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease
por: Carrizzo, Albino, et al.
Publicado: (2014)

Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation
por: Rangel-Barajas, Claudia, et al.
Publicado: (2016)

miRNA Regulation of Gene Expression: A Predictive Bioinformatics Analysis in the Postnatally Developing Monkey Hippocampus
por: Favre, Grégoire, et al.
Publicado: (2012)

Disruption of zinc transporter ZnT3 transcriptional activity and synaptic vesicular zinc in the brain of Huntington’s disease transgenic mouse
por: Niu, Li, et al.
Publicado: (2020)

Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration
por: Ardan, Taras, et al.
Publicado: (2019)

Ataxic Symptoms in Huntington’s Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone
por: Egorova, Polina A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3t7ptcaqq9af48qemgm8quhp9r